| Blood–brain barrier shuttle peptides: an emerging paradigm for brain delivery B Oller-Salvia, M Sánchez-Navarro, E Giralt, M Teixidó Chemical Society Reviews 45 (17), 4690-4707, 2016 | 428 | 2016 |
| Applying the retro‐enantio approach to obtain a peptide capable of overcoming the blood–brain barrier R Prades, B Oller‐Salvia, SM Schwarzmaier, J Selva, M Moros, M Balbi, ... Angewandte Chemie International Edition 54 (13), 3967-3972, 2015 | 166 | 2015 |
| MiniAp‐4: a venom‐inspired peptidomimetic for brain delivery B Oller‐Salvia, M Sánchez‐Navarro, S Ciudad, M Guiu, P Arranz‐Gibert, ... Angewandte Chemie 128 (2), 582-585, 2016 | 113 | 2016 |
| Rapid and Efficient Generation of Stable Antibody–Drug Conjugates via an Encoded Cyclopropene and an Inverse‐Electron‐Demand Diels–Alder Reaction B Oller‐Salvia, G Kym, JW Chin Angewandte Chemie International Edition 57 (11), 2831-2834, 2018 | 99 | 2018 |
| From venoms to BBB shuttles: synthesis and blood–brain barrier transport assessment of apamin and a nontoxic analog B Oller‐Salvia, M Teixidó, E Giralt Peptide Science 100 (6), 675-686, 2013 | 58 | 2013 |
| Efficient phage display with multiple distinct non‐canonical amino acids using orthogonal ribosome‐mediated genetic code expansion B Oller‐Salvia, JW Chin Angewandte Chemie 131 (32), 10960-10964, 2019 | 47 | 2019 |
| Branched BBB-shuttle peptides: chemoselective modification of proteins to enhance blood–brain barrier transport C Díaz-Perlas, B Oller-Salvia, M Sánchez-Navarro, M Teixidó, E Giralt Chemical science 9 (44), 8409-8415, 2018 | 47 | 2018 |
| The masking game: design of activatable antibodies and mimetics for selective therapeutics and cell control R Lucchi, J Bentanachs, B Oller-Salvia ACS central science 7 (5), 724-738, 2021 | 44 | 2021 |
| Phage Display as a Tool to Discover BBB-Shuttle Peptides: Panning Against a Human Blood-Brain Barrier Cellular Model C Díaz-Perlas, M Sánchez-Navarro, B Oller-Salvia, M Moreno Raja, ... Peptide Science 108 (1), e22928, 2017 | 34* | 2017 |
| Protease-resistant peptides for targeting and intracellular delivery of therapeutics MC Lucana, Y Arruga, E Petrachi, A Roig, R Lucchi, B Oller-Salvia Pharmaceutics 13 (12), 2065, 2021 | 28 | 2021 |
| High-efficacy subcellular micropatterning of proteins using fibrinogen anchors JL Watson, S Aich, B Oller-Salvia, AA Drabek, SC Blacklow, J Chin, ... Journal of Cell Biology 220 (2), 2021 | 19 | 2021 |
| Dual system for the central nervous system targeting and blood‐brain barrier transport of a selective prolyl oligopeptidase inhibitor M Teixidó, E Zurita, L Mendieta, B Oller‐Salvia, R Prades, T Tarragó, ... Peptide Science 100 (6), 662-674, 2013 | 11 | 2013 |
| Genetic encoding of a non-canonical amino acid for the generation of antibody-drug conjugates through a fast bioorthogonal reaction B Oller-Salvia JoVE (Journal of Visualized Experiments), e58066, 2018 | 9 | 2018 |
| Fortifier selection and dosage enables control of breast milk osmolarity A Herranz Barbero, N Rico, B Oller-Salvia, V Aldecoa-Bilbao, ... Plos one 15 (6), e0233924, 2020 | 7 | 2020 |
| Site-specific antibody masking enables conditional activation with different stimuli R Lucchi, MC Lucana, M Escobar-Rosales, C Díaz-Perlas, B Oller-Salvia New Biotechnology 78, 76-83, 2023 | 2 | 2023 |
| BrainBike peptidomimetic enables efficient transport of proteins across brain endothelium MC Lucana, R Lucchi, F Gosselet, C Díaz-Perlas, B Oller-Salvia RSC Chemical Biology 5 (1), 7-11, 2024 | | 2024 |
| Celebrem el Premi Nobel de Química 2022. Com la química clic i la química bioortogonal estan transformant la biomedicina? B Oller-Salvia Revista de la Societat Catalana de Química, 83-91, 2023 | | 2023 |
| Encoding Noncanonical Amino Acids into Phage Displayed Proteins C Díaz-Perlas, M Escobar-Rosales, CW Morgan, B Oller-Salvia Genetically Incorporated Non-Canonical Amino Acids: Methods and Protocols …, 2023 | | 2023 |
| Chemically Enhanced Peptide and Protein Therapeutics C Díaz-Perlas, B Oller-Salvia Pharmaceutics 15 (3), 827, 2023 | | 2023 |
| From bee venom to blood-brain barrier shuttles. Development of minimized apamin derivatives for brain delivery of antibodies and other cargoes B Oller Salvia Universitat de Barcelona, 2015 | | 2015 |
